Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan for ascites and hyponatremia in cirrhosis
NCT00501722Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of satavaptan in ascites, hyponatremia, sponsored by Sanofi. Started Apr 2004; status: completed.
02
Drugs
satavaptan
03
Conditions
asciteshyponatremia
Beyond the preview
Go deeper on NCT00501722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501722.